Toujeo

For people living with TIDM and T2DM The insulin of today
For a steady tomorrow

Stable control that lasts a full 24 hours and beyond

Stable activity profile

The HbA1C control you can expect

Lower risk of hypoglycemia vs. Lantus in people with T2DM

The confidence of glargine long-term CV safety

TOUJEO can be used in elderly people, patients with renal and hepatic impairment, children and adolescents from the age of 6 years.

A NEXT GENERATION BASAL INSULIN
FROM THE MAKERS OF LANTUS
insulin glargine 100U/mL

Toujeo insulin glargine 300u/mL
REDEFINING THE LIMITS OF CONTROL

Country/Market: South Africa
Target: Healthcare Professional (HCP)
Tagline: Redefining the limits of control
Size/duration: Single-page
Publication/Aired:
The Journal of Lifelong Learning - Modern Medicine - Volume 46 - number 1 - issue 1 - 2021
Brand files


Album name:	Admin / HCP - South Africa
Keywords:	Toujeo / _Toujeo_brand / Healthcare_category / English / hcpSouth_Africa / hcp / Print_Ad / Single-page / 2021_publication_year / TheJournalofLifelongLearningModernMedicineVolume46number1issue12021 / 111688 / Wuu8LR / Toujeo / _Toujeo_brand / Toujeo_DoubleStar / Insulin_glargine / Paediatric_Indication / Sanofi-Aventis / Sanofi / long-acting_basal_insulin_analogue / Endocrinology / diabetes / Healthcare_category / Green_Color / Purple_Color / _man / _male / Adult / Sun / Light / Ray / Shoulder / Day / Chartsinads more
Filesize:	6914 KiB
Date added:	Feb 25, 2021
IPTC Keywords:	[tagline]Redefining the limits of control[/tagline] Toujeo _Toujeo_brand Toujeo_DoubleStar Insulin_glargine Paediatric_Indication Sanofi-Aventis Sanofi long-acting_basal_insulin_analogue Endocrinology diabetes Healthcare_category Green_Color Purple_Color _man _male Adult Sun Light Ray Shoulder Day Chartsinads
My Collection:	Add to my collections
Dimensions:	4749 x 6600 pixels
URL:	https://adpharm.net/displayimage.php?pid=111688